[Advances in the treatment of liver disease].
D000596:Amino Acids / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002908:Chronic Disease; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004790:Enzyme Induction; D005078:Exchange Transfusion, Whole Blood; D006501:Hepatic Encephalopathy / Q000188:drug therapy / Q000628:therapy; D006505:Hepatitis / Q000188:drug therapy; D006506:Hepatitis A / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007792:Lactulose / Q000627:therapeutic use; D008107:Liver Diseases / Q000188:drug therapy*; D010530:Peritoneal Dialysis; D005719:gamma-Globulins / Q000627:therapeutic use
D000596:Amino Acids; D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D005719:gamma-Globulins; D007792:Lactulose; D004295:Dihydroxyphenylalanine
Fortschritte in der Therapie der Leberkrankheiten.